Literature DB >> 23416840

Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.

Ravi Nistala1, Adam Whaley-Connell.   

Abstract

The presence of insulin resistance is increasingly recognized as an important contributor to early stage kidney disease independent of the contribution of diabetes. Important in this relationship is the strong correlation between hyperinsulinemia and low levels of albuminuria (e.g. microalbuminuria). Recent work highlight mechanisms for glomerular/tubulointerstitial injury with excess insulin and emerging evidence identifies a unique role for insulin metabolic signaling and altered handling of salt reabsorption at the level of the proximal tubule. Evidence is also emerging for the role of insulin signaling in the glomerulus both epithelial and endothelial. Central to the mechanism of injury is inappropriate activation of the RAAS.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiorenal metabolic syndrome; Chronic kidney disease; Glomerulus; Hyperinsulinemia; Insulin resistance; Obesity

Mesh:

Substances:

Year:  2013        PMID: 23416840      PMCID: PMC3711952          DOI: 10.1016/j.mce.2013.02.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  77 in total

1.  High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.

Authors:  Sang Youb Han; Young Sun Kang; Yi Hwa Jee; Kum Hyun Han; Dae Ryong Cha; Shin Wook Kang; Dae Suk Han
Journal:  Cell Tissue Res       Date:  2005-09-28       Impact factor: 5.249

Review 2.  Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.

Authors:  Melvin R Hayden; Adam Whaley-Connell; James R Sowers
Journal:  Am J Nephrol       Date:  2005 Nov-Dec       Impact factor: 3.754

Review 3.  Renal tubule albumin transport.

Authors:  Michael Gekle
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

4.  The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

5.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

6.  Insulin resistance and risk of chronic kidney disease in nondiabetic US adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.

Authors:  Yongzhong Wei; Adam T Whaley-Connell; Kemin Chen; Javad Habibi; Grace M-E Uptergrove; Suzanne E Clark; Craig S Stump; Carlos M Ferrario; James R Sowers
Journal:  Hypertension       Date:  2007-05-28       Impact factor: 10.190

Review 9.  Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes.

Authors:  Swasti Tiwari; Shahla Riazi; Carolyn A Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-08

10.  Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.

Authors:  Shinya Ogasawara; Michihiro Hosojima; Ryohei Kaseda; Hideyuki Kabasawa; Keiko Yamamoto-Kabasawa; Hiroyuki Kurosawa; Hiroyoshi Sato; Noriaki Iino; Tetsuro Takeda; Yoshiki Suzuki; Ichiei Narita; Kunihiro Yamagata; Yasuhiko Tomino; Fumitake Gejyo; Yoshiaki Hirayama; Sakari Sekine; Akihiko Saito
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

View more
  8 in total

1.  mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats.

Authors:  Ravi Nistala; Ahmad Raja; Lakshmi Pulakat
Journal:  Can J Physiol Pharmacol       Date:  2017-01-04       Impact factor: 2.273

Review 2.  Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2017-09-30       Impact factor: 2.041

3.  Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.

Authors:  Nitin A Das; Andrea J Carpenter; Anthony Belenchia; Annayya R Aroor; Makoto Noda; Ulrich Siebenlist; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cell Signal       Date:  2019-12-17       Impact factor: 4.315

4.  Inhibition of tumor necrosis factor-α enhanced the antifibrotic effect of empagliflozin in an animal model with renal insulin resistance.

Authors:  Hoda E Mohamed; Mervat E Asker; Mohammed M Keshawy; Rehab A Hasan; Yasmin K Mahmoud
Journal:  Mol Cell Biochem       Date:  2020-01-13       Impact factor: 3.842

5.  The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.

Authors:  Javad Habibi; Annayya R Aroor; Nitin A Das; Camila M Manrique-Acevedo; Megan S Johnson; Melvin R Hayden; Ravi Nistala; Charles Wiedmeyer; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2019-03-25       Impact factor: 9.951

6.  Hyperinsulinemia Can Cause Kidney Disease in the IGT Stage of OLETF Rats via the INS/IRS-1/PI3-K/Akt Signaling Pathway.

Authors:  Yi Zhang; Shaohua Yang; Xiao Cui; Juhong Yang; Miaoyan Zheng; Junya Jia; Fei Han; Xiaoyun Yang; Jingyu Wang; Zhenhong Guo; Bai Chang; Baocheng Chang
Journal:  J Diabetes Res       Date:  2019-10-13       Impact factor: 4.011

7.  Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.

Authors:  Annayya Aroor; Marcin Zuberek; Cornel Duta; Alex Meuth; James R Sowers; Adam Whaley-Connell; Ravi Nistala
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

8.  Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes.

Authors:  Anton I Korbut; Vadim V Klimontov; Ilya V Vinogradov; Vyacheslav V Romanov
Journal:  World J Diabetes       Date:  2019-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.